Vaibhav A Medhekar, MD
Internal Medicine · Fremont
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
Offices
3 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Medhekar’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A127355 · Current
Licensed to practise in California · since 2013 · expires 2027-05-31 · David Geffen School of Medicine at UCLA.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$32,476
Medicare paid this office $32,476 for 167 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 91 | $11,943 | $98 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 40 | $6,225 | $156 |
| Short return visit (20+ min) | 67 | $5,797 | $72 |
Who their Medicare patients are
167 Original Medicare patients in 2024. Average age 74 · Women 34% · Also on Medicaid 7% · Health risk score 1.06. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 64% · Diabetes 32% · Coronary heart disease 28% · Chronic kidney disease 19% · Cancer 15% · Depression 15% · Atrial fibrillation 11% · Heart failure 7%.
The office billed $98,796, Medicare allowed $43,991 and paid $32,476; for 322 services of 28 kinds; $2,626 of it was for drugs given in the office and $29,850 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 167 | 322 | 74 | 1.06 | $98,796 | $32,476 |
| 2023 | 189 | 334 | 75 | 1.13 | $98,566 | $34,468 |
| 2022 | 84 | 150 | 73 | 0.66 | $72,938 | $12,740 |
| 2021 | 450 | 771 | 73 | 0.67 | $98,119 | $28,858 |
| 2020 | 148 | 297 | 71 | 0.68 | $84,085 | $15,388 |
| 2019 | 99 | 193 | 70 | 0.86 | $63,795 | $12,235 |
| 2017 | 46 | 77 | 69 | 0.61 | $24,812 | $4,672 |
| 2016 | 71 | 140 | 69 | 0.62 | $38,276 | $8,216 |
| 2015 | 14 | 20 | 62 | 1.94 | $9,221 | $2,202 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Return visit (30+ min) | 122 | $18,755 | $113 |
| Short return visit (20+ min) | 58 | $4,708 | $76 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 21 | $3,212 | $153 |
| Long return visit (40+ min) | 17 | $2,675 | $157 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 17 | $1,289 | $76 |
| Administration of influenza virus vaccine | 17 | $617 | $36 |
2022: 2 services
| Short return visit (20+ min) | 39 | $4,038 | $79 |
| Return visit (30+ min) | 27 | $3,544 | $104 |
2021: 8 services
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted; second dose | 331 | $10,001 | $30 |
| Return visit (30+ min) | 46 | $7,198 | $103 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted; first dose | 250 | $4,239 | $17 |
| Short return visit (20+ min) | 21 | $2,017 | $84 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 11 | $1,724 | $157 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 11 | $725 | $66 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 18 | $448 | $25 |
| Administration of influenza virus vaccine | 12 | $251 | $21 |
2020: 4 services
| Return visit (30+ min) | 38 | $4,089 | $83 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 56 | $3,416 | $61 |
| Short return visit (20+ min) | 32 | $2,236 | $47 |
| Administration of influenza virus vaccine | 60 | $1,254 | $21 |
2019: 4 services
| Short return visit (20+ min) | 45 | $4,585 | $66 |
| Return visit (30+ min) | 22 | $2,254 | $87 |
| Administration of influenza virus vaccine | 19 | $383 | $20 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 12 | $224 | $19 |
2017: 2 services
| Return visit (30+ min) | 14 | $798 | $44 |
| Short return visit (20+ min) | 14 | $600 | $37 |
2016: 4 services
| Return visit (30+ min) | 24 | $2,219 | $79 |
| Short return visit (20+ min) | 14 | $1,228 | $58 |
| Administration of influenza virus vaccine | 27 | $875 | $32 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) | 17 | $271 | $16 |
Drugs they prescribed that Part D paid
$122,386
Pharmacies billed $122,386 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,426 generic and fewer than 11 brand-name prescriptions · $122,386 in drug cost · 32 antibiotic prescriptions to 25 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 17 | $29,058 | $1,709 |
| Jardiance | 12 | $20,851 | $1,738 |
| Mounjaro | 14 | $16,697 | $1,193 |
| Atorvastatin | 172 | $1,565 | $9 |
| Rosuvastatin | 101 | $1,396 | $14 |
See all 31 drugs
| Ozempic | 17 | $29,058 | $1,709 |
| Jardiance | 12 | $20,851 | $1,738 |
| Mounjaro | 14 | $16,697 | $1,193 |
| Atorvastatin | 172 | $1,565 | $9 |
| Rosuvastatin | 101 | $1,396 | $14 |
| Metoprolol | 65 | $904 | $14 |
| Losartan | 87 | $878 | $10 |
| Amlodipine Besylate | 129 | $820 | $6 |
| Gabapentin | 44 | $680 | $15 |
| Tamsulosin | 41 | $672 | $16 |
| Lisinopril | 44 | $600 | $14 |
| Pantoprazole | 31 | $560 | $18 |
| Synthroid | 14 | $473 | $34 |
| Finasteride | 27 | $458 | $17 |
| Albuterol Sulfate Hfa | 17 | $449 | $26 |
| Omeprazole | 34 | $419 | $12 |
| Levothyroxine | 39 | $364 | $9 |
| Ezetimibe | 16 | $313 | $20 |
| Metformin | 32 | $288 | $9 |
| Metformin Hcl Er | 28 | $254 | $9 |
| Hydrochlorothiazide | 27 | $228 | $8 |
| Losartan-Hydrochlorothiazide | 21 | $225 | $11 |
| Spironolactone | 21 | $182 | $9 |
| Clonidine | 12 | $152 | $13 |
| Lisinopril-Hydrochlorothiazide | 27 | $104 | $4 |
| Hydrocortisone | 13 | $91 | $7 |
| Trazodone | 14 | $86 | $6 |
| Atenolol | 13 | $82 | $6 |
| Pravastatin | 12 | $79 | $7 |
| Lorazepam | 17 | $21 | $1 |
| Paxlovid | 12 | $0 | $0 |
Year by year
| 2024 | 1,560 | 216 | None | None | $122,386 |
| 2023 | 679 | 193 | None | 6% | $60,028 |
| 2022 | 210 | 58 | 0% (0) | None | $7,478 |
| 2021 | 167 | 37 | 0% (0) | 10% | $13,246 |
| 2020 | 200 | 75 | 0% (0) | 8% | $8,382 |
| 2019 | 723 | 191 | None | None | $29,093 |
| 2018 | 940 | 279 | 4% (39) | None | $46,281 |
| 2017 | 241 | 107 | 6% (15) | None | $8,359 |
| 2016 | 87 | 23 | None | 23% | $4,933 |
| 2015 | 44 | None | None | None | $725 |
| 2014 | 84 | 16 | None | 24% | $4,138 |
| 2013 | 35 | None | 0% (0) | None | $885 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 15 drugs
| Diclofenac | 21 | $2,215 | $105 |
| Atorvastatin | 63 | $734 | $12 |
| Rosuvastatin | 37 | $730 | $20 |
| Amlodipine Besylate | 44 | $553 | $13 |
| Metoprolol | 17 | $439 | $26 |
| Losartan | 37 | $429 | $12 |
| Albuterol Sulfate Hfa | 13 | $414 | $32 |
| Levothyroxine | 25 | $365 | $15 |
| Gabapentin | 14 | $280 | $20 |
| Paxlovid (Eua) | 25 | $262 | $10 |
| Metformin | 15 | $241 | $16 |
| Pantoprazole | 14 | $234 | $17 |
| Lisinopril | 19 | $224 | $12 |
| Metformin Hcl Er | 13 | $57 | $4 |
| Lorazepam | 18 | $30 | $2 |
2022: 5 drugs
| Atorvastatin | 36 | $474 | $13 |
| Rosuvastatin | 12 | $370 | $31 |
| Levothyroxine | 15 | $350 | $23 |
| Metformin | 11 | $158 | $14 |
| Amlodipine Besylate | 16 | $120 | $7 |
2021: 2 drugs
| Atorvastatin | 26 | $693 | $27 |
| Amlodipine Besylate | 26 | $241 | $9 |
2020: 2 drugs
| Atorvastatin | 33 | $706 | $21 |
| Amlodipine Besylate | 21 | $197 | $9 |
2019: 16 drugs
| Atorvastatin | 87 | $2,084 | $24 |
| Diclofenac | 11 | $1,118 | $102 |
| Levothyroxine | 32 | $876 | $27 |
| Tamsulosin | 30 | $838 | $28 |
| Lisinopril | 48 | $559 | $12 |
| Terazosin | 14 | $531 | $38 |
| Amlodipine Besylate | 33 | $438 | $13 |
| Losartan | 28 | $335 | $12 |
| Gabapentin | 11 | $321 | $29 |
| Metoprolol | 11 | $311 | $28 |
| Metoprolol | 25 | $288 | $12 |
| Hydrochlorothiazide | 24 | $256 | $11 |
| Fluticasone Propionate | 11 | $166 | $15 |
| Simvastatin | 14 | $153 | $11 |
| Famotidine | 11 | $137 | $12 |
| Atenolol | 11 | $131 | $12 |
2018: 26 drugs
| Diclofenac | 25 | $2,600 | $104 |
| Atorvastatin | 80 | $2,146 | $27 |
| Qvar | 18 | $1,891 | $105 |
| Tamsulosin | 39 | $1,056 | $27 |
| Ventolin Hfa | 23 | $1,032 | $45 |
| Gabapentin | 22 | $627 | $28 |
| Levothyroxine | 21 | $601 | $29 |
| Lisinopril | 45 | $530 | $12 |
| Terazosin | 17 | $500 | $29 |
| Pantoprazole | 24 | $464 | $19 |
| Amlodipine Besylate | 42 | $322 | $8 |
| Fluticasone Propionate | 23 | $301 | $13 |
| Finasteride | 12 | $285 | $24 |
| Losartan | 19 | $277 | $15 |
| Losartan-Hydrochlorothiazide | 13 | $267 | $21 |
| Doxycycline Monohydrate | 15 | $231 | $15 |
| Famotidine | 17 | $226 | $13 |
| Hydrocodone-Acetaminophen | 20 | $215 | $11 |
| Glipizide | 11 | $185 | $17 |
| Prednisone | 12 | $183 | $15 |
| Trazodone | 14 | $164 | $12 |
| Montelukast | 11 | $146 | $13 |
| Ibuprofen | 12 | $142 | $12 |
| Citalopram Hbr | 15 | $125 | $8 |
| Metoprolol | 11 | $115 | $10 |
| Meloxicam | 12 | $92 | $8 |
2017: 2 drugs
| Atorvastatin | 11 | $343 | $31 |
| Fluticasone Propionate | 11 | $144 | $13 |
2014: 3 drugs
| Pravastatin | 14 | $350 | $25 |
| Metoprolol | 13 | $44 | $3 |
| Lisinopril | 12 | $40 | $3 |
Professional record
- NPI
- 1104141282
- Licence
- CA 127355California A127355: Current · expires 2027-05-31
- Trained
- University of California, Geffen School of Medicine, 2010
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2010-04-01
- NPI last updated
- 2023-01-10
- NPI record certified
- 2023-01-10
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 3850 Grand Ave, Oakland, CA, 94610 · 3885 24th St, San Francisco, CA, 94114